175 related articles for article (PubMed ID: 37336131)
1. The efficacy and tolerability of adjunctive brivaracetam for the treatment of adult epilepsy: An Australian multi-center retrospective real-world observational cohort study.
Halliday AJ; Vogrin S; Ignatiadis S; Gillinder L; Jones D; Kiley M; Kwan P; Seneviratne U; Somerville E; Whitham E;
Epilepsy Behav; 2023 Aug; 145():109287. PubMed ID: 37336131
[TBL] [Abstract][Full Text] [Related]
2. Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures.
Brandt C; Dimova S; Elmoufti S; Laloyaux C; Nondonfaz X; Klein P
Epilepsy Behav; 2023 Jan; 138():108967. PubMed ID: 36435010
[TBL] [Abstract][Full Text] [Related]
3. BRIVEST: A 'real-world' observational, single-centre study investigating the efficacy, safety and tolerability of Brivaracetam.
Naddell S; Manuel M; Cavill R; White P; Sieradzan K
Epilepsy Behav; 2023 Jan; 138():108985. PubMed ID: 36442261
[TBL] [Abstract][Full Text] [Related]
4. Safety, tolerability, and efficacy of brivaracetam as adjunctive therapy in patients with focal seizures, generalized onset seizures, or Unverricht-Lundborg disease: An open-label, long-term follow-up trial.
Ben-Menachem E; Baulac M; Hong SB; Cleveland JM; Reichel C; Schulz AL; Wagener G; Brandt C
Epilepsy Res; 2021 Feb; 170():106526. PubMed ID: 33461041
[TBL] [Abstract][Full Text] [Related]
5. Effect of Number of Previous Antiseizure Medications on Efficacy and Tolerability of Adjunctive Brivaracetam for Uncontrolled Focal Seizures: Post Hoc Analysis.
Lee SK; Heo K; Kim SE; Lee SA; Elmoufti S; Laloyaux C; Hur B
Adv Ther; 2021 Jul; 38(7):4082-4099. PubMed ID: 34155568
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records.
Villanueva V; Laloyaux C; D'Souza W; Faught E; Klein P; Reuber M; Rosenow F; Salas-Puig J; Insuga VS; Strzelczyk A; Szaflarski JP; Chinn C; Daniels T; Floricel F; Friesen D; Sendersky V; Besson H; Steinhoff BJ
CNS Drugs; 2023 Sep; 37(9):819-835. PubMed ID: 37684497
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST).
Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Chiesa V; Dainese F; De Maria G; Didato G; Falcicchio G; Fanella M; Ferlazzo E; Fisco G; Gangitano M; Giallonardo AT; Giorgi FS; La Neve A; Mecarelli O; Montalenti E; Piazza F; Pulitano P; Quarato PP; Ranzato F; Rosati E; Tassi L; Di Bonaventura C;
CNS Drugs; 2021 Dec; 35(12):1289-1301. PubMed ID: 34476770
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
[TBL] [Abstract][Full Text] [Related]
9. Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST).
Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Irelli EC; Chiesa V; Dainese F; De Maria G; Didato G; Gennaro GD; Falcicchio G; Fanella M; Ferlazzo E; Gangitano M; La Neve A; Mecarelli O; Montalenti E; Morano A; Piazza F; Pizzanelli C; Pulitano P; Ranzato F; Rosati E; Tassi L; Di Bonaventura C;
Seizure; 2022 Apr; 97():37-42. PubMed ID: 35320736
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Tolerability of Adjunctive Brivaracetam in Patients with Focal-Onset Seizures on Specific Concomitant Antiseizure Medications: Pooled Analysis of Double-Blind, Placebo-Controlled Trials.
Moseley B; Bourikas D; Dimova S; Elmoufti S; Borghs S
Adv Ther; 2024 Apr; 41(4):1746-1758. PubMed ID: 38356105
[TBL] [Abstract][Full Text] [Related]
11. Retention of brivaracetam in adults with drug-resistant epilepsy at a single tertiary care center.
Green SF; Hare N; Kassam M; Rugg-Gunn F; Koepp MJ; Sander JW; Rajakulendran S
Epilepsy Behav; 2022 Oct; 135():108868. PubMed ID: 35985166
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and tolerability of adjunctive brivaracetam in patients with focal seizures: Second interim analysis of 6-month data from a prospective observational study in Europe.
Steinhoff BJ; Christensen J; Doherty CP; Majoie M; De Backer M; Hellot S; Leunikava I; Leach JP
Epilepsy Res; 2020 Sep; 165():106329. PubMed ID: 32623096
[TBL] [Abstract][Full Text] [Related]
13. Brivaracetam efficacy and tolerability in clinical practice: A UK-based retrospective multicenter service evaluation.
Adewusi J; Burness C; Ellawela S; Emsley H; Hughes R; Lawthom C; Maguire M; McLean B; Mohanraj R; Oto M; Singhal S; Reuber M
Epilepsy Behav; 2020 May; 106():106967. PubMed ID: 32179501
[TBL] [Abstract][Full Text] [Related]
14. Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials.
Ryvlin P; Dimova S; Elmoufti S; Floricel F; Laloyaux C; Nondonfaz X; Biton V
Epilepsia; 2022 Aug; 63(8):2024-2036. PubMed ID: 35582748
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive brivaracetam - A prospective audit of outcomes from an epilepsy clinic.
Stephen L; Brodie MJ
Epilepsy Behav; 2021 Mar; 116():107746. PubMed ID: 33517200
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of adjuvant perampanel: an Australian multicenter real-world observational study in refractory focal and generalized epilepsy syndromes.
Sagar P; Wawryk O; Vogrin S; Whitham E; Kiley M; Frasca J; Carne R; Seneviratne U; Cook MJ; Lawn N; Nikpour A; D'Souza WJ
Epilepsy Behav; 2021 Jun; 119():107935. PubMed ID: 33930626
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety and efficacy of brivaracetam in adults with focal seizures: Results from an open-label, multinational, follow-up trial.
Arnold S; Laloyaux C; Schulz AL; Elmoufti S; Yates S; Fakhoury T
Epilepsy Res; 2020 Oct; 166():106404. PubMed ID: 32731118
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy and tolerability of adjunctive brivaracetam in adults with focal to bilateral tonic-clonic (secondary generalized) seizures: Post hoc pooled analysis.
Moseley BD; Dimova S; Elmoufti S; Laloyaux C; Asadi-Pooya AA
Epilepsy Res; 2021 Oct; 176():106694. PubMed ID: 34218211
[TBL] [Abstract][Full Text] [Related]
19. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy.
Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Cerulli Irelli E; Chiesa V; Dainese F; De Maria G; Didato G; Di Gennaro G; Falcicchio G; Fanella M; Ferlazzo E; Gangitano M; La Neve A; Mecarelli O; Montalenti E; Morano A; Piazza F; Pizzanelli C; Pulitano P; Ranzato F; Rosati E; Tassi L; Di Bonaventura C;
Epilepsia; 2023 Nov; 64(11):2922-2933. PubMed ID: 38079181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
